Does CRISABOROLE Cause Therapeutic product effect incomplete? 202 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Therapeutic product effect incomplete have been filed in association with CRISABOROLE (Eucrisa). This represents 2.6% of all adverse event reports for CRISABOROLE.
202
Reports of Therapeutic product effect incomplete with CRISABOROLE
2.6%
of all CRISABOROLE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From CRISABOROLE?
Of the 202 reports, 1 (0.5%) resulted in death, 1 (0.5%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRISABOROLE. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does CRISABOROLE Cause?
Drug ineffective (1,815)
Application site pain (1,414)
Burning sensation (975)
Off label use (673)
Condition aggravated (613)
Pain (468)
Pruritus (378)
Rash (342)
Eczema (308)
Erythema (285)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which CRISABOROLE Alternatives Have Lower Therapeutic product effect incomplete Risk?
CRISABOROLE vs CRIZANLIZUMAB
CRISABOROLE vs CRIZANLIZUMAB-TMCA
CRISABOROLE vs CRIZOTINIB
CRISABOROLE vs CROFELEMER
CRISABOROLE vs CROMOLYN